For many of us, with a visual fidelity this good, Star Wars Battlefront is a fantasy come true. Does it live up to its own hype?
The Force Awakens in Star Wars Battlefront - Our Review!
Closing out the trilogy, Legacy of the Void will leave you complete and at a loss all in one!
StarCraft 2: Legacy of the Void: Our In-Depth Review!
We knew it would be something, but we didn't quite know just how good that something would be!
Fall in Love with Fallout 4 - Our Complete Review!
We take on Lara's exploits once again. Is there enough treasure here for a true dig?
Rise of the Tomb Raider - Our In-Depth Review!
Post by Eorl @ 03:42pm 04/07/14 | 0 Comments
BioWare has today confirmed that veteran companion Leliana will be returning in Dragon Age: Inquisition, though it seems she's upgraded her skills during her absence.

A new profile page on the Dragon Age: Inquisition website reveals that while she was perhaps more keen on bard abilities in the past, stealthier skills may come to the fore in the next entry in the series. She has many names," it reads.
"Most know her as Sister Nightingale or the Left Hand of the Divine. To the rare friend, she is Leliana. They say she found faith amid darkness, and that her devotion to the Maker is matched only by her devotion to Divine Justinia V, a woman who is both mentor and savior. Those who have earned her loyalty know her as a steadfast ally. But enemies of the Divine know to fear her, for she is the shadow behind the Sunburst Throne—the one who watches and waits, who strikes when her mark is most vulnerable and least suspecting.”
Leliana made her debut in BioWare's first Dragon Age title, Origins, however also took centre stage in Leliana's Song DLC. She later returned in Dragon Age 2, though wasn't available as a playable character.

Dragon Age: Inquisition is scheduled for launch on PC, PlayStation 3, PlayStation 4, Xbox One and Xbox 360 come October 9th.

dragon age: inquisitionbiowarelelianaplayable character

Latest Comments
No comments currently exist. Be the first to comment!
Commenting has been locked for this item.